ETFs With Abbott Laboratories (ABT) Exposure
The following ETFs maintain significant exposure to Abbott Laboratories (ABT); each of the following funds counts ABT among its top ten individual holdings. Note that percentages in the table reflect weightings at the beginning of the current month, and are subject to change.
To see a complete breakdown of any of the ETFs included in the table below, including sector, market cap, and country allocations, click on the ticker symbol.
|Ticker||ETF||ETFdb Category||Expense Ratio||Weighting|
|IHE||iShares U.S. Pharmaceuticals ETF||Health & Biotech Equities||0.48%||5.52%|
|PJP||Dynamic Pharmaceuticals||Health & Biotech Equities||0.60%||4.75%|
|PPH||Market Vectors Pharmaceutical ETF||Health & Biotech Equities||0.35%||4.57%|
|VIG||Dividend Appreciation ETF||Large Cap Value Equities||0.10%||4.11%|
|EZY||LargeCap Value Fund||Large Cap Value Equities||0.38%||3.38%|
|FMK||Mega Cap AlphaDEX Fund||Large Cap Blend Equities||0.70%||3.23%|
|SPHD||S&P 500 High Dividend Portfolio||Large Cap Value Equities||0.30%||2.90%|
|IYH||iShares U.S. Healthcare ETF||Health & Biotech Equities||0.48%||2.77%|
|VHT||Health Care ETF||Health & Biotech Equities||0.14%||2.65%|
|FXH||Health Care AlphaDEX||Health & Biotech Equities||0.70%||2.37%|
|PXLC||RAFI Fundamental Pure Large Core Portfolio||Large Cap Blend Equities||0.39%||2.35%|
|RPX||Growth Equity Strategy Fund||Large Cap Growth Equities||0.89%||1.91%|
© 2013 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.